McGowan Group Asset Management »

Jazz Pharmaceuticals shares owned by McGowan Group Asset Management

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by McGowan Group Asset Management from 13F filings

Historical chart of McGowan Group Asset Management investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by McGowan Group Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by McGowan Group Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $5.0M 47k 106.12
2025-03-31 $6.0M 48k 124.15
2024-12-31 $6.0M 49k 123.15
2015-06-30 $365k 2.1k 175.90

More positions owned by McGowan Group Asset Management

General Mny Mkt Fund Money Market
Nuveen Global High Income SHS (JGH)
AllianceBernstein Global Hgh Incm (AWF)
BlackRock Corporate High Yield Fund VI (HYT)
Doubleline Income Solutions (DSL)
Cohen & Steers infrastucture Fund (UTF)
British Amern Tob Sponsored Adr (BTI)
Exxon Mobil Corporation (XOM)
Plains Gp Hldgs L P Ltd Partner Int Cl A N Ltd Partnr Int A (PAGP)
Ares Capital Corporation (ARCC)
Bwx Technologies (BWXT)
3M Company (MMM)
Eaton V.Tax-Advantaged Dividend Inc Fund (EVT)
Dell Technologies Inc Cl C CL C (DELL)
Goldman Sachs Etf Tr Tr Access Ultra Short Ultra Short Bond (GSST)

View all positions for McGowan Group Asset Management

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Dimensional Fund Advisors
Capital World Investors
LSV Asset Management
State Street Corporation
Jpmorgan Chase & Co
Ameriprise Financial
EcoR1 Capital
Hanna Zanoni
Geode Capital Management
GoldenTree Asset Management
Swedbank AB
Citadel Advisors
Renaissance Technologies

View all funds holding Jazz Pharmaceuticals